Skip to main content

PhD research improving HIV disclosure practices in Malawi

Alumni News

Malawi has made immense strides in combating its HIV epidemic since it introduced free antiretroviral therapy (ART) in 2004. However, Malawi’s HIV prevalence remains one of the highest in the world, and of the 1 million estimated people living with the virus, 84,000 are children under the age of 14.

Fatch Kalembo.
Fatch Kalembo is helping to improve the lives of children living with HIV in Malawi.

Moreover, the current rate of disclosure of HIV status to children in sub-Saharan Africa remains low – below 40 per cent – despite the World Health Organisation stating that children should be told of their HIV status between the ages of six and 12 years.

Non-disclosure has been associated with lack of ART medication adherence, and has the potential for children to transmit the virus once they reach adolescence and engage in sexual activity.

Fatch Kalembo is a native Malawian and registered nurse whose PhD research at Curtin is set to dramatically improve HIV disclosure practices to children in Malawi and other sub-Saharan countries.

“Currently there are many children who are growing up without knowing they have HIV, or they are inappropriately disclosed to, which can have a negative impact on their mental wellbeing,” Kalembo says.

Kalembo and his research team from Curtin and the University of Malawi are developing a series of age-appropriate children’s books that will help inform HIV positive children about their illness, and how they can manage their disease to go on to lead happy, fulfilling lives.

The books will use pictures, stories and songs in local Malawian languages to educate children about HIV. They will be gifted to all children living with HIV for their sixth, eighth, 10th and 12th birthdays, with each series containing age-appropriate content.

“The provision of free ART has made a huge impact on the physical health of people living with HIV, but there is gap that is not being addressed, and that is the psychosocial wellbeing of people living with HIV,” says Kalembo.

“These books will address that gap, so when a child goes to a clinic to get their medication, they will also receive appropriate education about living with the disease.

“The books will tell them what exercises to do, the best types of food to eat and help answer any questions they might have, such as what if they want to get married when they grow up? What about their education and future?

“There is plenty of discrimination towards HIV sufferers in Malawi, so these books will also help children develop resilience and understand that even though they have this disease, there are still steps they can take to live physically and mentally well.”

In addition to the books, Kalembo and his team have developed training manuals for healthcare workers, parents and primary caregivers on how to provide appropriate disclosure and use the books effectively to teach children about their HIV status.

“Many parents and healthcare workers don’t have the confidence to disclose because they lack the materials to guide them,” Kalembo says.

The manuals will also include information for how other stakeholders, such as the Malawian government, community leaders and school teachers, can work together to provide standardised HIV disclosure practices.

“Through my studies, I found that the people who are supporting children with HIV are working in isolation, so it’s very difficult to organise and action the care that should be given.

“What we intend to do is provide such information that each stakeholder will know what role they are supposed to play in the development and support of children with HIV.”

Kalembo has received multiple awards and scholarships for his pivotal PhD research, including Best Research Project for African PhD Students by UNESCO and the pharmaceutical company, MERCK. In 2017 and 2018 he was awarded scholarships to present his research at international AIDS conferences in Paris and Amsterdam respectively.

Once the disclosure books and training manuals have been published, Kalembo will travel back to Malawi to evaluate their impact on the treatment and wellbeing of children living with HIV. If successful, Kalembo hopes to translate the materials into additional languages and distribute them to other countries in Africa and around the world.

“It would be a dream come true to be able to contribute to the wellbeing of these children; to help them to lead fulfilling lives and contribute to the economic development of Malawi.”

About Fatch Kalembo

Fatch Kalembo graduated from the University of Malawi with a Bachelor of Science (Nursing) in 2003 and a University Certificate in Midwifery in 2006. He went on to complete his Master of Public Health at Huazhong University of Science and Technology in China in 2013. He has recently graduated with a PhD from Curtin and is now completing his postdoctoral studies, which will evaluate the impact of his HIV disclosure materials.

Give a birthday gift to children living with HIV

Help Malawian children living with HIV receive a book for their 6th, 8th, 10th and 12th birthdays. These story books will guide parents, healthcare workers, teachers and community leaders in the disclosure process to ensure positive mental, social and physical health outcomes for children living with HIV in Malawi. Give now.



Share your thoughts on this story (comments are moderated in advance).

This story has 1 comment

  1. Lt. Chisomo Kayanula says:

    This is a very beautiful development in an area that has been neglected for sometime. Despite making huge strides in reducing AIDS related deaths through the use of ARVs, paediatric HIV care has been neglected for a long time. I, myself being a practicing clinical registered nurse working in Malawi, have had two or three cases involving dilemmas viz-a-viz peadiatric disclosure of HIV. One 14 year old girl was never told why she had to take pills everyday and this led to anger which consequently led to poor adherence as stated in the article and later to frequent hospitalization. This poses a risk of drug failure/drug resistance so as an example I really want to concur with Fatch how important this program would be if it reached the peadiatric masses affected.

Your comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.